132 related articles for article (PubMed ID: 6203661)
1. Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in saline.
Slevin ML; Harvey VJ; Aherne GW; Burton NK; Johnston A; Wrigley PF
Cancer Chemother Pharmacol; 1984; 13(1):19-21. PubMed ID: 6203661
[TBL] [Abstract][Full Text] [Related]
2. A pharmacokinetic evaluation of IM administration of bleomycin oil suspension.
Davy M; Paus E; Lehne G
Cancer Chemother Pharmacol; 1985; 14(3):274-6. PubMed ID: 2581717
[TBL] [Abstract][Full Text] [Related]
3. [Distribution of bleomycin in sesame oil suspension in organs of rat with mammary carcinoma induced by 7,12-dimethylbenz (a) anthracene and its effect on the tumors (author's transl)].
Tominaga T; Tei N; Kitamura TM; Azuma Y; Horibata A
Jpn J Antibiot; 1975 Dec; 28(6):753-7. PubMed ID: 53298
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of bleomycin released from the lymphatic system.
Ziółko E; Muc-Wierzgoń M
Haematologia (Budap); 1995; 26(3):147-50. PubMed ID: 7541012
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous infusion of bleomycin--a practical alternative to intravenous infusion.
Harvey VJ; Slevin ML; Aherne GW; Littleton P; Johnston A; Wrigley PF
J Clin Oncol; 1987 Apr; 5(4):648-50. PubMed ID: 2435856
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of bleomycin following intravenous infusion as determined by radioimmunoassay.
Broughton A; Strong JE; Holoye PY; Bedrossian CW
Cancer; 1977 Dec; 40(6):2772-8. PubMed ID: 73408
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of bleomycin after im administration in man.
Oken MM; Crooke ST; Elson MK; Strong JE; Shafer RB
Cancer Treat Rep; 1981; 65(5-6):485-9. PubMed ID: 6165473
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin clinical pharmacology by radioimmunoassay.
Hall SW; Strong JE; Broughton A; Frazier ML; Benjamin RS
Cancer Chemother Pharmacol; 1982; 9(1):22-5. PubMed ID: 6183016
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of bleomycin in man.
Kramer WG; Feldman S; Broughton A; Strong JE; Hall SW; Holoye PY
J Clin Pharmacol; 1978 Jul; 18(7):346-52. PubMed ID: 78932
[TBL] [Abstract][Full Text] [Related]
10. Continuous infusion versus intermittent bolus injection of bleomycin in a human embryonal testicular cancer xenograft.
Osieka R; Glatte P; Schmidt CG
Cancer Treat Rep; 1984 May; 68(5):799-801. PubMed ID: 6202408
[TBL] [Abstract][Full Text] [Related]
11. [Effects of radiotherapy combined with daily intramuscular injection of bleomycin for uterine cervical cancer].
Ishigaki T; Sakuma S
Gan To Kagaku Ryoho; 1983 Mar; 10(3):829-33. PubMed ID: 6192769
[TBL] [Abstract][Full Text] [Related]
12. Studies on the clinical pharmacology of bleomycin.
Crooke ST; Comis RI; Einhorn LH; Strong JE; Broughton A; Prestayko AW
Recent Results Cancer Res; 1978; 63():219-29. PubMed ID: 81504
[No Abstract] [Full Text] [Related]
13. Pharmacokinetics of tallysomycin and bleomycin in the beagle dog.
Strong JE; Schurig JE; Issell BF; Kramer WG; Tavel AF; Florczyk AP; Crooke ST
Cancer Treat Rep; 1979; 63(11-12):1821-7. PubMed ID: 93509
[TBL] [Abstract][Full Text] [Related]
14. [Effect of continuous bleomycin treatment and of oil-suspended bleomycin on experimental tumor growth (author's transl)].
Urano M; Koike S; Ando K; Nesumi N; Sukuki Y
Jpn J Antibiot; 1976 Aug; 29(8):721-4. PubMed ID: 60500
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of a continuous infusion with a daily bolus injection of bleomycin in a heterotransplanted human testicular cancer].
Osieka R
Arzneimittelforschung; 1984; 34(4):460-4. PubMed ID: 6204651
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin pharmacology in relation to adverse effects and renal function in cervical cancer patients.
Petrilli ES; Castaldo TW; Matutat RJ; Ballon SC; Gutierrez ML
Gynecol Oncol; 1982 Dec; 14(3):350-4. PubMed ID: 6185395
[No Abstract] [Full Text] [Related]
17. [Decreased pulmonary toxicity in continuous subcutaneous infusion and consecutive daily injection of peplomycin in testicular tumor patients].
Satake I; Tari K; Suzuki F; Yoshida S
Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2291-7. PubMed ID: 2420909
[No Abstract] [Full Text] [Related]
18. [Clinical study of the auxiliary action of bleomycin in surgery and radiotherapy of cervical cancer and evaluation of modes of administration for the enhancement of the effects and alleviation of the adverse effects].
Takada M
Gan To Kagaku Ryoho; 1983 May; 10(5):1285-92. PubMed ID: 6191679
[TBL] [Abstract][Full Text] [Related]
19. [Effects of conformation radiotherapy combined with daily intramuscular injection of bleomycin for uterine cervical cancer (author's transl)].
Mimura M; Ishigaki T; Niwa K; Ishikawa T; Toyama J; Banno T; Mizutani M; Makino N; Mizutani H; Kamata N; Imagunbai N; Sakuma S; Koike K; Yagami Y
Rinsho Hoshasen; 1980 Nov; 25(12):1311-6. PubMed ID: 6162043
[No Abstract] [Full Text] [Related]
20. Cisplatin-induced changes in bleomycin elimination.
Yee GC; Crom WR; Champion JE; Brodeur GM; Evans WE
Cancer Treat Rep; 1983 Jun; 67(6):587-9. PubMed ID: 6190560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
